Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
Samuel Bitoun,
Xavier Mariette,
Jerome Avouac,
Raphaele Seror,
Gaetane Nocturne,
Flore Rozenberg,
Julien Henry,
Rakiba Belkhir,
Omar Al Tabaa,
Roba Ghossan,
Alice Andrée Mariaggi,
Christelle Vauloup-Fellous
Affiliations
Samuel Bitoun
1 Department of Rheumatology, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1184, Le Kremlin Bicêtre, France
Xavier Mariette
Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud – Hôpital Bicêtre, Le Kremlin Bicêtre, France
Jerome Avouac
Service de Rhumatologie, Hôpital Cochin, AP-HP.CUP, Universite de Paris, Paris, France
Raphaele Seror
Department of Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicetre, France
Gaetane Nocturne
Department of Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicetre, France
Flore Rozenberg
5 Université de Paris, Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Virologie, Paris, France
Julien Henry
Department of Rheumatology, AP-HP, Paris-Sud University Hospitals, Le Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France
Rakiba Belkhir
Rheumatology, Assistance Publique – Hôpitaux de Paris, Hospital Bicetre, Le Kremlin-Bicetre, France
Omar Al Tabaa
Rheumatology, Assistance Publique – Hôpitaux de Paris, Hospital Bicetre, Le Kremlin-Bicetre, France
Roba Ghossan
Rheumatology, Université Paris Cité Hôpital Cochin, AP-HP.CUP, Paris, France
Alice Andrée Mariaggi
Virology Department, Université Paris Cité, Hôpital Cochin, AP-HP.CUP, Paris, France
Christelle Vauloup-Fellous
Division of Virology, Department of Biology Genetics and PUI, Paris Saclay University Hospital, APHP, INSERM U1193, Université Paris Saclay, Villejuif, France